Association between metabolic syndrome and clinicopathological features of papillary thyroid cancer

BACKGROUND: Metabolic syndrome (MetS) was a risk factor for papillary thyroid cancer (PTC). Whether MetS impacts the aggressiveness of PTC is still unclear. We carried out this study to clarify this issue. METHODS: We evaluated 745 consecutive PTC patients treated with surgery. Patients were divided...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jun-Long, Li, Ling-Rui, Yu, Xi-Zi, Zhan, Ling, Xu, Zhi-Liang, Li, Juan-Juan, Sun, Sheng-Rong, Chen, Chuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617556/
https://www.ncbi.nlm.nih.gov/pubmed/34826117
http://dx.doi.org/10.1007/s12020-021-02940-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617556/
https://www.ncbi.nlm.nih.gov/pubmed/34826117
http://dx.doi.org/10.1007/s12020-021-02940-6

Ejemplares similares